{
  "symbol": "AARTIPHARM.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2021-03-31",
      "quarter": "Q1 2021",
      "fiscal_year": 2021,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 11920336000.0,
      "gross_profit": 3123343000.0,
      "operating_income": 1651623000.0,
      "ebitda": 1978391000.0,
      "net_income": 1222511000.0,
      "diluted_eps": null,
      "total_assets": 20398996000.0,
      "total_liabilities": 6534218000.0,
      "total_equity": 13864778000.0,
      "total_debt": 3414005000.0,
      "cash_and_equivalents": 832734000.0,
      "current_assets": 10281474000.0,
      "current_liabilities": 5806649000.0,
      "operating_cash_flow": -437038000.0,
      "investing_cash_flow": -1387389000.0,
      "financing_cash_flow": 2603834000.0,
      "free_cash_flow": -1848558000.0,
      "capex": -1411520000.0,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.24623582144625755,
      "current_ratio": 1.7706381081412015,
      "operating_margin": 13.85550709308865,
      "net_profit_margin": 10.255675678940595,
      "roe": 8.817386041089154,
      "roa": 5.992995929799682,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 16.59677210441048,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 19360045000.0,
      "gross_profit": 6820366000.0,
      "operating_income": 2795088000.0,
      "ebitda": 3443692000.0,
      "net_income": 1934934000.0,
      "diluted_eps": null,
      "total_assets": 22440238000.0,
      "total_liabilities": 6855372000.0,
      "total_equity": 15584866000.0,
      "total_debt": 2153128000.0,
      "cash_and_equivalents": 121212000.0,
      "current_assets": 11630059000.0,
      "current_liabilities": 6006234000.0,
      "operating_cash_flow": 2501154000.0,
      "investing_cash_flow": -1578030000.0,
      "financing_cash_flow": -1634646000.0,
      "free_cash_flow": 1304585000.0,
      "capex": -1196569000.0,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.13815505375535472,
      "current_ratio": 1.9363313184268212,
      "operating_margin": 14.437404458512365,
      "net_profit_margin": 9.994470570703735,
      "roe": 12.415467672291825,
      "roa": 8.622609082844843,
      "debt_to_fcf_ratio": 1.6504313632304526,
      "ebitda_margin": 17.787623944055916,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 18155052000.0,
      "gross_profit": 7024428000.0,
      "operating_income": 3128117000.0,
      "ebitda": 3909420000.0,
      "net_income": 2169021000.0,
      "diluted_eps": null,
      "total_assets": 25821051000.0,
      "total_liabilities": 8250659000.0,
      "total_equity": 17570392000.0,
      "total_debt": 2852540000.0,
      "cash_and_equivalents": 236349000.0,
      "current_assets": 13456410000.0,
      "current_liabilities": 6943891000.0,
      "operating_cash_flow": 2163546000.0,
      "investing_cash_flow": -2145644000.0,
      "financing_cash_flow": 97235000.0,
      "free_cash_flow": 175695000.0,
      "capex": -1987851000.0,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.16234925208270823,
      "current_ratio": 1.9378774810837325,
      "operating_margin": 17.230008484690654,
      "net_profit_margin": 11.947203456095858,
      "roe": 12.344750191116965,
      "roa": 8.400204159001893,
      "debt_to_fcf_ratio": 16.235749452175646,
      "ebitda_margin": 21.533510341914745,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 20860021000.0,
      "gross_profit": 8675427000.0,
      "operating_income": 3774667000.0,
      "ebitda": 4744899000.0,
      "net_income": 2724048000.0,
      "diluted_eps": null,
      "total_assets": 29064051000.0,
      "total_liabilities": 9164987000.0,
      "total_equity": 19899064000.0,
      "total_debt": 4208179000.0,
      "cash_and_equivalents": 67337000.0,
      "current_assets": 13221672000.0,
      "current_liabilities": 6570495000.0,
      "operating_cash_flow": 3315615000.0,
      "investing_cash_flow": -4138977000.0,
      "financing_cash_flow": 654350000.0,
      "free_cash_flow": -1123169000.0,
      "capex": -4438784000.0,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.21147622822862422,
      "current_ratio": 2.012279440133506,
      "operating_margin": 18.095221476526795,
      "net_profit_margin": 13.058702098142664,
      "roe": 13.689327297002512,
      "roa": 9.37256819429611,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 22.746376909208287,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    }
  ]
}